Elvira M. Davelaar

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum

Elvira M. Davelaar, Gerard J. van Kamp, Rob A. Verstraeten et al. · Clinical Chemistry · 1998 · 52 citations · Full text

Medicine, Oncology, Cancer Screening +14

SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer

Jonas van de Lande, Elvira M. Davelaar, Silvia von Mensdorff‐Pouilly et al. · Gynecologic Oncology · 2008 · 51 citations

Medicine, Oncology, Surgery +14

The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass

Eltjo M.J. Schutter, Elvira M. Davelaar, Gerard J. van Kamp et al. · American Journal of Obstetrics and Gynecology · 2002 · 40 citations

Medicine, Oncology, Pathology +14

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

Marc Daniël Algera, Willemien J. van Driel, B.F.M. Slangen et al. · Gynecologic Oncology · 2022 · 33 citations · Full text

Medicine, Oncology, Surgery +12

CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?

Elvira M. Davelaar, Johannes M.G. Bonfrèr, Rob A. Verstraeten et al. · Cancer · 1996 · 32 citations

Medicine, Gynecology, Oncology +17